General Information of the Compound
| Compound ID |
CP0547087
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1S,9S,10S)-17-methyl-4-(1,1,2,2,2-pentafluoroethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H22F5N
|
||||||||||||||||||
| Molecular Weight |
359.382
|
||||||||||||||||||
| Canonical SMILES |
CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(cc31)C(F)(F)C(F)(F)F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H22F5N/c1-25-9-8-17-7-3-2-4-14(17)16(25)10-12-5-6-13(11-15(12)17)18(20,21)19(22,23)24/h5-6,11,14,16H,2-4,7-10H2,1H3/t14-,16+,17+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
AFLNMGAGYFICEC-PVAVHDDUSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03632, Sigma intracellular receptor 2
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter